MedPath

Effect of internal administration of triphaladhyam taila formulation followed by therapeutic purgation with triphala powder in reducing the body mass index of patients who are overweight

Phase 3
Conditions
Health Condition 1: E663- Overweight
Registration Number
CTRI/2024/06/069078
Lead Sponsor
PALLAVY JAYAKUMAR
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

BMI ranging from 25kg/m2 to 29.9kg/m2

Exclusion Criteria

Patients on long term steroid treatment

Those who are suffering from severe hypertension,type 2 diabetes mellitus with evidence of renal,hepatic and cardiac involvement

Pregnant women and lactating mothers

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath